These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11912023)

  • 21. Human immunodeficiency virus type 1 protease inhibitor attenuates Candida albicans virulence properties in vitro.
    Gruber A; Speth C; Lukasser-Vogl E; Zangerle R; Borg-von Zepelin M; Dierich MP; Würzner R
    Immunopharmacology; 1999 Apr; 41(3):227-34. PubMed ID: 10428651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral Candida colonization and its relation with predisposing factors in HIV-infected children and their uninfected siblings in Brazil: the era of highly active antiretroviral therapy.
    Cerqueira DF; Portela MB; Pomarico L; de Araújo Soares RM; de Souza IP; Castro GF
    J Oral Pathol Med; 2010 Feb; 39(2):188-94. PubMed ID: 20040023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Candida proteases and their inhibition: prospects for antifungal therapy.
    Stewart K; Abad-Zapatero C
    Curr Med Chem; 2001 Jul; 8(8):941-8. PubMed ID: 11375761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The crystal structure of protease Sapp1p from Candida parapsilosis in complex with the HIV protease inhibitor ritonavir.
    Dostál J; Brynda J; Hrušková-Heidingsfeldová O; Pachl P; Pichová I; Rezáčová P
    J Enzyme Inhib Med Chem; 2012 Feb; 27(1):160-5. PubMed ID: 22146051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Species distribution and antifungal susceptibility profile of oral candida isolates from HIV-infected patients in the antiretroviral therapy era.
    Costa CR; de Lemos JA; Passos XS; de Araújo CR; Cohen AJ; Souza LK; Silva Mdo R
    Mycopathologia; 2006 Jul; 162(1):45-50. PubMed ID: 16830191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in oropharyngeal colonization and infection by Candida albicans in human immunodeficiency virus-infected patients.
    Diz Dios P; Ocampo A; Otero I; Iglesias I; Martínez C
    J Infect Dis; 2001 Jan; 183(2):355-356. PubMed ID: 11120936
    [No Abstract]   [Full Text] [Related]  

  • 27. Impact of protease inhibitor therapy on HIV-related oropharyngeal candidiasis.
    Arribas JR; Hernández-Albujar S; González-García JJ; Peña JM; Gonzalez A; Cañedo T; Madero R; Vazquez JJ; Powderly WG
    AIDS; 2000 May; 14(8):979-85. PubMed ID: 10853979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insight into the structural similarity between HIV protease and secreted aspartic protease-2 and binding mode analysis of HIV-Candida albicans inhibitors.
    Calugi C; Guarna A; Trabocchi A
    J Enzyme Inhib Med Chem; 2013 Oct; 28(5):936-43. PubMed ID: 22803674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Longitudinal study of anti-Candida albicans mucosal immunity against aspartic proteinases in HIV-infected patients.
    Millon L; Drobacheff C; Piarroux R; Monod M; Reboux G; Laurent R; Meillet D
    J Acquir Immune Defic Syndr; 2001 Feb; 26(2):137-44. PubMed ID: 11242180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of prolonged HAART on oral colonization with Candida and candidiasis.
    Yang YL; Lo HJ; Hung CC; Li Y
    BMC Infect Dis; 2006 Jan; 6():8. PubMed ID: 16423306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of Candida albicans secreted aspartic protease by a novel series of peptidomimetics, also active on the HIV-1 protease.
    Skrbec D; Romeo D
    Biochem Biophys Res Commun; 2002 Oct; 297(5):1350-3. PubMed ID: 12372437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel Aggregation Properties of Candida albicans Secreted Aspartyl Proteinase Sap6 Mediate Virulence in Oral Candidiasis.
    Kumar R; Saraswat D; Tati S; Edgerton M
    Infect Immun; 2015 Jul; 83(7):2614-26. PubMed ID: 25870228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Secreted aspartic proteases as virulence factors of Candida species.
    Monod M; Borg-von ZM
    Biol Chem; 2002; 383(7-8):1087-93. PubMed ID: 12437091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Salivary lactoferrin in HIV-infected children: correlation with Candida albicans carriage, oral manifestations, HIV infection and its antifungal activity.
    Alves TP; Simões AC; Soares RM; Moreno DS; Portela MB; Castro GF
    Arch Oral Biol; 2014 Aug; 59(8):775-82. PubMed ID: 24837476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Virulence of oral Candida isolated from HIV-positive women with oral candidiasis and asymptomatic carriers.
    Owotade FJ; Patel M
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Oct; 118(4):455-60. PubMed ID: 25201119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Virulence factors and genetic variability of vaginal Candida albicans isolates from HIV-infected women in the post-highly active antiretroviral era.
    Zanni PCMD; Bonfim-Mendonça PS; Negri M; Nakamura SS; Donatti L; Svidzinski TIE; Consolaro MEL
    Rev Inst Med Trop Sao Paulo; 2017; 59():e44. PubMed ID: 28793015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of highly active antiretroviral therapy on frequency of oral warts.
    Greenspan D; Canchola AJ; MacPhail LA; Cheikh B; Greenspan JS
    Lancet; 2001 May; 357(9266):1411-2. PubMed ID: 11356441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adherence of different Candida dubliniensis isolates in the presence of fluconazole.
    Borg-von Zepelin M; Niederhaus T; Gross U; Seibold M; Monod M; Tintelnot K
    AIDS; 2002 Jun; 16(9):1237-44. PubMed ID: 12045488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dissimilar attenuation of Candida albicans virulence properties by human immunodeficiency virus type 1 protease inhibitors.
    Gruber A; Berlit J; Speth C; Lass-Flörl C; Kofler G; Nagl M; Borg-von Zepelin M; Dierich MP; Würzner R
    Immunobiology; 1999 Sep; 201(1):133-44. PubMed ID: 10532286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral candidiasis in HIV+ patients under treatment with protease inhibitors.
    Witzel AL; Silveira FR; Pires Mde F; Lotufo MA
    Braz Oral Res; 2008; 22(4):371-7. PubMed ID: 19148395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.